Emcure Q2 FY27: Revenue rises 24.3% to INR 28,205 Mn, EBITDA jumps 30.9% and PAT increases 29.3% to INR 3,251 Mn.
Read MorePharmaceutical companies
Tredence Acquires KMK Consulting, Targets 25% Revenue from Healthcare by 2028
KMK Consulting joins Tredence to strengthen AI capabilities in healthcare and life sciences, accelerating growth in the global HLS market.
Read More

